University of Dundee

Bridget Ogilvie Lecture 2019 - ‘Targeting huntingtin for the treatment of Huntington’s disease’

Event Date: 
Monday, November 11, 2019 - 13:00
Event Location: 
MSI Large Lecture Theatre
Professor Claire Halpin FRSE FRSB
Professor Dario Alessi FRS FRSE FMedSci
Event Speaker: 
Professor Gill Bates
UCL Queen Square Institute of Neurology
Event Type: 
Named Lecture




The talk will be followed by refreshments in WTB Atrium/Life Space, to which everyone is invited.


 Dr. Gillian Bates is Professor of Molecular Neuroscience, co-Director of the Huntington’s Disease Centre and Vice Dean (Research), Faculty of Brain Sciences at UCL. During her postdoctoral work she was a key player in the team that, in 1993, cloned the Huntington’s disease gene. She developed the first mouse model of HD and her research programme is directed toward understanding the molecular basis of HD and validating therapeutic targets. She has been elected to the Academy of Medical Sciences (1999), European Molecular Biology Organisation (2002) and the Royal Society (2007). Prizes have included the Royal Society Glaxo Wellcome Award (with Stephen Davies) (1998), the Max Planck Research Award for International Cooperation (1999), the Klaus Joachim Zülch-Preis (2001) and the Leslie Brenner Gehry Prize for Innovation in Science (2011).


About the lecture series:

The Bridget Ogilvie Lecture is named after Dame Bridget Ogilvie who was Director of the Wellcome Trust 1991 - 1998 and who played an important role in the development of the College of Life Sciences, in particular in the special award of £10 million that lead to the building of the Wellcome Trust Building in 1997.  Each Wellcome funded Division in SLS takes turns in nominating the Bridget Ogilvie Lecturer and this year is the turn of MRC/PPU.